Journal of Clinical Gynecology and Obstetrics, ISSN 1927-1271 print, 1927-128X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Gynecol Obstet and Elmer Press Inc
Journal website http://www.jcgo.org

Original Article

Volume 5, Number 2, June 2016, pages 59-63


Comparison of Oral Versus Vaginal Misoprostol for Legal Abortion in Iranian Women

Figure

Figure 1.
Figure 1. Flow diagram of the progress through the phases of a two-group parallel randomized trial.

Tables

Table 1. The Comparison of Variables in Two Oral and Vaginal Misoprostol Groups
 
Variable groupsOralVaginalP value
*t-test. **Chi-square.
Age, mean (SD)30.7 (7.09)28.8 (6.52)0.24*
Gestational age, mean (SD)14.3 (3.42)14.5 (2.68)0.18*
Gravidity, no. (%)
  111 (31.4)12 (34.3)0.51**
  212 (34.3)14 (40)
  3 and more12 (34.3)9 (25.7)
Delivery mode, no. (%)
  NVD12 (34.3)12 (34.3)1**
  Cesarean section5 (14.3)5 (14.3)
  No18 (51.4)18 (51.4)
History of abortion, no. (%)
  Yes12 (34.3)10 (28.6)0.607*
  No23 (65.7)25 (71.4)
Number of used pills
  12 (5.7)2 (5.7)0.88*
  212 (34.3)8 (22.9)
  35 (14.3)7 (20)
  46 (17.1)6 (17.1)
  53 (8.6)4 (11.4)
  68 (22.9)8 (22.9)

 

Table 2. Comparison of the Frequency of Treatment Response to Misoprostol, the Need for Curettage and Complications in Two Groups
 
GroupsOral, no. (%)Vaginal, no. (%)P value
Treatment response to misoprostol
  Yes29 (82.8)28 (80)0.75
  No6 (17.2)7 (20)
The need for curettage
  Yes12 (34.3)15 (42.8)0.461
  No23 (65.7)20 (57.2)
Complications
  Yes2 (100)0 (0)0.493
  No33 (48.5)35 (51.5)